安捷伦(A)第四季度财报即将揭晓：分析师解读关键绩效指标 - 雅虎财经
Agilent (A) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
#Analysts' Insights#Key Performance#Performance Measures#Yahoo Finance#Measures Yahoo
生命科学资讯
生物技术与制药领域的最新动态
沃特斯公司股票2025年能否创历史新高——季度投资组合评估与技术分析确认交易动态
Will Waters Corporation stock reach all time highs in 2025 - Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
#Quarterly Portfolio#Portfolio Review#Technical Analysis#Waters Corporation#Trade Confirmation
C. Light公司项目入选罗氏多发性硬化创新挑战赛五大精选项目——雅虎财经报道
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
#Light Named#Selected Projects#Innovation Challenge#Yahoo Finance#Challenge Yahoo
Sapphiros与罗氏达成战略合作，为罗氏提供10亿次侧流检测及未来分子即时检测服务 - 雅虎财经
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
#providing Roche#Yahoo Finance#Roche access#billion lateral#future molecular
Thermo Fisher Scientific推出业界首款多参数分子检测试剂，用于快速饮料质量检测——晨星报
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing - Morningstar
#Fisher Scientific#Scientific Launches#Molecular Assay#Rapid Beverage#Beverage Quality
KaliVir Immunotherapeutics宣布与罗氏达成临床试验合作与供应协议，共同评估VET3-TGI联合阿特珠单抗（Tecentriq®）治疗晚期实体瘤的效果——雅虎财经报道
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
#Immunotherapeutics Announces#Announces Clinical#Clinical Trial#Trial Collaboration#Supply Agreement
安捷伦科技公司股票动量指标分析——2025年技术形态与周度收益优化方案 - 新社网
What momentum indicators show for Agilent Technologies Inc. stock - 2025 Technical Patterns & Weekly Return Optimization Plans - newser.com
#Agilent Technologies#Technical Patterns#Weekly Return#Return Optimization#Optimization Plans
奥莱玛制药(OLMA)在罗氏乳腺癌试验成功后重新审视竞争优势 - 雅虎财经
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
#Rethinks Competitive#Competitive Edge#Breast Cancer#Cancer Trial#Olema Pharmaceuticals
安捷伦科技投资者复苏布局分析——市场趋势报告与AI优化交易策略指南——newser.com
Analyzing recovery setups for Agilent Technologies Inc. investors - Market Trend Report & AI Optimized Trading Strategy Guides - newser.com
#Agilent Technologies#Market Trend#Trend Report#Optimized Trading#Trading Strategy
卖出ILMN的三大理由及一个替代买入股票 - Finviz
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz
#Sell ILMN#Reasons#Stock#Sell#ILMN
Thermo Fisher Scientific (TMO)旗下EXENT系统获FDA批准对股东意味着什么 - simplywall.st
What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders - simplywall.st
#Fisher Scientific#Thermo Fisher#FDA Clearance#EXENT System#Shareholders simplywall.st
罗氏：乳腺癌候选药物Giredestrant数据支持其潜在差异化地位——晨星加拿大
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
#Breast Cancer#Cancer Drug#Drug Candidate#Candidate Giredestrant#Giredestrant Support
避免投资TXG的三大理由及一只替代股票推荐 - Finviz
3 Reasons to Avoid TXG and 1 Stock to Buy Instead - Finviz
#Avoid TXG#Reasons#Stock#Avoid#TXG
彭博社：孤星、阿尔塔里斯与One Rock竞购龙沙资产
Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com
#Lone Star#Lonza Assets#Assets Bloomberg.com#Altaris#Bloomberg.com Lone
Freenome与罗氏合作，为非美国市场开发癌症筛查技术 - 医疗器械网络
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
#Medical Device#Device Network#Roche partner#cancer screening#screening technology
创意规划增持安捷伦科技股份$A——MarketBeat报道
Creative Planning Grows Stock Position in Agilent Technologies, Inc. $A - MarketBeat
#Agilent Technologies#Planning Grows#Grows Stock#Stock Position#Creative Planning
随着Madrigal面临MASH竞争对手，留住患者与寻找新患者同等重要。
As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones
#MASH rivals#faces MASH#drug Rezdiffra#exceeded expectations#Madrigal faces
安捷伦科技公司2025年股票展望——投资者要点与长期增长投资组合规划 - 新瑟网
Agilent Technologies Inc. stock outlook for YEAR - 2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
#Investor Takeaways#Agilent Technologies#Growth Portfolio#Long-Term Growth#Portfolio Plans
欧盟委员会批准罗氏Lunsumio皮下注射剂用于复发或难治性滤泡性淋巴瘤——雅虎财经
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
#Yahoo Finance#European Commission#Commission approves#approves Roche#Lunsumio subcutaneous
安捷伦科技(AG8)股票是否准备好迎接数字化转型——周投资回顾与基于AI的买卖信号——newser.com
Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com
#Agilent Technologies#Weekly Investment#Investment Recap#Based Buy#Sell Signals